MedPath

Randomised crossover trial of a porous haemodialysis membrane compared to a conventional high-flux membrane in stable haemodialysis patients to determine the short term impact on inflammatory and nutritional indices.

Phase 4
Completed
Conditions
Haemodialysis
End Stage Renal Failure
Renal and Urogenital - Other renal and urogenital disorders
Registration Number
ACTRN12606000132549
Lead Sponsor
Fresenius
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Stable haemodialysis patients, currently dialysed with FX60 dialysers.

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath